Experiments in mice have shown that the lack of IP10 or its receptor reduces the severity of ARDS during influenza virus infection, suggesting the potential of this signaling pathway as a therapeutic target for ARDS treatment (156). This evidence concerns the gene CXCL10 and acute respiratory distress syndrome.